The long-term mission of the Mayo Clinic Comprehensive Metabolomics Research Core (MCCMRC) is to facilitate access to metabolomic techniques for use in both basic and disease-oriented research while continuously developing novel methodologies designed to better understand the metabolic derangements present in disease. The Core will also enhance awareness of and education on the potential application of metabolomics tools in research. The administrative core of MCCMRC is intended to help create and foster such an interactive and productive environment and will take advantage of Mayo's unique strengths and track record in metabolic research including an established Metabolomics Core and multiple investigators with extramural funding for research programs based on metabolomic techniques. The Core is strengthened by integration of the NMRS facility to the Metabolomics Core enhancing the availability of advanced mass spectrometry techniques. The MCCMRC's global efforts will be enhanced by substantial institutional resources including a Center for Translational Science Activities (CTSA) grant and complementary institutional cores. Ultimately, the MCCMRC will enhance and expand the collaborative intersections and critical mass of scientists utilizing metabolomic techniques in disease-oriented research. The administrative core will be the link between the Metabolomics Core, Mayo Clinic Leadership and National Consortium leadership. The administrative core will help to achieve the goals of the MCCMRC by coordinating the goals set by the program director in consultation with the internal and external advisory committees. Moreover, the administrative core will oversee the hiring and training of additional staff, installation of additional equipment, establishing techniques and quality control measures. It will facilitate the activities of the Promotion and Outreach core which will include developing course work for new investigators and a Request For Applications for pilot and feasibility projects. It is anticipated that the new services will be available in years 2-3. Years 4-5 will be focused on outreach efforts to expand the investigator pool. By the end of the 5 year period we will transition to a self-sustaining model through the implementation of a fee-for-service cost recovery model. This process will be guided and supported through the administrative infrastructure in place to support core billing and compliance. In addition, the administrative core will oversee and prioritize requests for resource sharing both intramurally and extramurally.

Public Health Relevance

This proposal is prepared in response to RFA-RM-11-016: Regional Comprehensive Metabolomics Resource Cores (RCMRC) (U24). The administrative core will oversee this initiative and facilitate the transition to a self-sustaining model for funding ensuring the long term success of the Mayo Clinic Comprehensive Metabolomics Research Core (MCCMRC) and its stated goals.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Resource-Related Research Projects--Cooperative Agreements (U24)
Project #
1U24DK100469-01
Application #
8694167
Study Section
Special Emphasis Panel (ZRG1-BST-F (50))
Project Start
Project End
Budget Start
2013-09-10
Budget End
2014-08-31
Support Year
1
Fiscal Year
2013
Total Cost
$558,995
Indirect Cost
$207,426
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
006471700
City
Rochester
State
MN
Country
United States
Zip Code
55905
Zabielski, Piotr; Lanza, Ian R; Gopala, Srinivas et al. (2016) Altered Skeletal Muscle Mitochondrial Proteome As the Basis of Disruption of Mitochondrial Function in Diabetic Mice. Diabetes 65:561-73
Kakazu, Eiji; Mauer, Amy S; Yin, Meng et al. (2016) Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner. J Lipid Res 57:233-45
Basu, Ananda; Veettil, Sona; Dyer, Roy et al. (2016) Direct Evidence of Acetaminophen Interference with Subcutaneous Glucose Sensing in Humans: A Pilot Study. Diabetes Technol Ther 18 Suppl 2:S243-7
Hinshaw, Ling; Schiavon, Michele; Dadlani, Vikash et al. (2016) Effect of Pramlintide on Postprandial Glucose Fluxes in Type 1 Diabetes. J Clin Endocrinol Metab 101:1954-62
Irving, Brian A; Wood, G Craig; Bennotti, Peter N et al. (2016) Nutrient Transporter Expression in the Jejunum in Relation to Body Mass Index in Patients Undergoing Bariatric Surgery. Nutrients 8:
Vella, Adrian; Jensen, Michael D; Nair, K Sreekumaran (2016) Eulogy for the Metabolic Clinical Investigator? Diabetes 65:2821-3
Kline, Timothy L; Irazabal, Maria V; Ebrahimi, Behzad et al. (2016) Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease. Magn Reson Med 75:1466-73
O'Neill, Brian T; Lee, Kevin Y; Klaus, Katherine et al. (2016) Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. J Clin Invest 126:3433-46
Johnson, Matthew L; Distelmaier, Klaus; Lanza, Ian R et al. (2016) Mechanism by Which Caloric Restriction Improves Insulin Sensitivity in Sedentary Obese Adults. Diabetes 65:74-84
Savica, Rodolfo; Murray, Melissa E; Persson, Xuan-Mai et al. (2016) Plasma sphingolipid changes with autopsy-confirmed Lewy Body or Alzheimer's pathology. Alzheimers Dement (Amst) 3:43-50

Showing the most recent 10 out of 62 publications